Cargando…
The impact of dupilumab treatment on severe acute respiratory syndrome coronavirus 2-coronavirus disease 2019 antibody responses in patients with atopic dermatitis
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American College of Allergy, Asthma & Immunology. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956356/ https://www.ncbi.nlm.nih.gov/pubmed/35346880 http://dx.doi.org/10.1016/j.anai.2022.03.019 |
| _version_ | 1784676550653771776 |
|---|---|
| author | Ungar, Benjamin Lavin, Leore Golant, Alexandra K. Gontzes, Alyssa David, Eden Estrada, Yeriel D. Singer, Giselle K. Pavel, Ana B. Guttman-Yassky, Emma |
| author_facet | Ungar, Benjamin Lavin, Leore Golant, Alexandra K. Gontzes, Alyssa David, Eden Estrada, Yeriel D. Singer, Giselle K. Pavel, Ana B. Guttman-Yassky, Emma |
| author_sort | Ungar, Benjamin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8956356 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89563562022-03-28 The impact of dupilumab treatment on severe acute respiratory syndrome coronavirus 2-coronavirus disease 2019 antibody responses in patients with atopic dermatitis Ungar, Benjamin Lavin, Leore Golant, Alexandra K. Gontzes, Alyssa David, Eden Estrada, Yeriel D. Singer, Giselle K. Pavel, Ana B. Guttman-Yassky, Emma Ann Allergy Asthma Immunol Letters American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2022-06 2022-03-26 /pmc/articles/PMC8956356/ /pubmed/35346880 http://dx.doi.org/10.1016/j.anai.2022.03.019 Text en © 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letters Ungar, Benjamin Lavin, Leore Golant, Alexandra K. Gontzes, Alyssa David, Eden Estrada, Yeriel D. Singer, Giselle K. Pavel, Ana B. Guttman-Yassky, Emma The impact of dupilumab treatment on severe acute respiratory syndrome coronavirus 2-coronavirus disease 2019 antibody responses in patients with atopic dermatitis |
| title | The impact of dupilumab treatment on severe acute respiratory syndrome coronavirus 2-coronavirus disease 2019 antibody responses in patients with atopic dermatitis |
| title_full | The impact of dupilumab treatment on severe acute respiratory syndrome coronavirus 2-coronavirus disease 2019 antibody responses in patients with atopic dermatitis |
| title_fullStr | The impact of dupilumab treatment on severe acute respiratory syndrome coronavirus 2-coronavirus disease 2019 antibody responses in patients with atopic dermatitis |
| title_full_unstemmed | The impact of dupilumab treatment on severe acute respiratory syndrome coronavirus 2-coronavirus disease 2019 antibody responses in patients with atopic dermatitis |
| title_short | The impact of dupilumab treatment on severe acute respiratory syndrome coronavirus 2-coronavirus disease 2019 antibody responses in patients with atopic dermatitis |
| title_sort | impact of dupilumab treatment on severe acute respiratory syndrome coronavirus 2-coronavirus disease 2019 antibody responses in patients with atopic dermatitis |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956356/ https://www.ncbi.nlm.nih.gov/pubmed/35346880 http://dx.doi.org/10.1016/j.anai.2022.03.019 |
| work_keys_str_mv | AT ungarbenjamin theimpactofdupilumabtreatmentonsevereacuterespiratorysyndromecoronavirus2coronavirusdisease2019antibodyresponsesinpatientswithatopicdermatitis AT lavinleore theimpactofdupilumabtreatmentonsevereacuterespiratorysyndromecoronavirus2coronavirusdisease2019antibodyresponsesinpatientswithatopicdermatitis AT golantalexandrak theimpactofdupilumabtreatmentonsevereacuterespiratorysyndromecoronavirus2coronavirusdisease2019antibodyresponsesinpatientswithatopicdermatitis AT gontzesalyssa theimpactofdupilumabtreatmentonsevereacuterespiratorysyndromecoronavirus2coronavirusdisease2019antibodyresponsesinpatientswithatopicdermatitis AT davideden theimpactofdupilumabtreatmentonsevereacuterespiratorysyndromecoronavirus2coronavirusdisease2019antibodyresponsesinpatientswithatopicdermatitis AT estradayerield theimpactofdupilumabtreatmentonsevereacuterespiratorysyndromecoronavirus2coronavirusdisease2019antibodyresponsesinpatientswithatopicdermatitis AT singergisellek theimpactofdupilumabtreatmentonsevereacuterespiratorysyndromecoronavirus2coronavirusdisease2019antibodyresponsesinpatientswithatopicdermatitis AT pavelanab theimpactofdupilumabtreatmentonsevereacuterespiratorysyndromecoronavirus2coronavirusdisease2019antibodyresponsesinpatientswithatopicdermatitis AT guttmanyasskyemma theimpactofdupilumabtreatmentonsevereacuterespiratorysyndromecoronavirus2coronavirusdisease2019antibodyresponsesinpatientswithatopicdermatitis AT ungarbenjamin impactofdupilumabtreatmentonsevereacuterespiratorysyndromecoronavirus2coronavirusdisease2019antibodyresponsesinpatientswithatopicdermatitis AT lavinleore impactofdupilumabtreatmentonsevereacuterespiratorysyndromecoronavirus2coronavirusdisease2019antibodyresponsesinpatientswithatopicdermatitis AT golantalexandrak impactofdupilumabtreatmentonsevereacuterespiratorysyndromecoronavirus2coronavirusdisease2019antibodyresponsesinpatientswithatopicdermatitis AT gontzesalyssa impactofdupilumabtreatmentonsevereacuterespiratorysyndromecoronavirus2coronavirusdisease2019antibodyresponsesinpatientswithatopicdermatitis AT davideden impactofdupilumabtreatmentonsevereacuterespiratorysyndromecoronavirus2coronavirusdisease2019antibodyresponsesinpatientswithatopicdermatitis AT estradayerield impactofdupilumabtreatmentonsevereacuterespiratorysyndromecoronavirus2coronavirusdisease2019antibodyresponsesinpatientswithatopicdermatitis AT singergisellek impactofdupilumabtreatmentonsevereacuterespiratorysyndromecoronavirus2coronavirusdisease2019antibodyresponsesinpatientswithatopicdermatitis AT pavelanab impactofdupilumabtreatmentonsevereacuterespiratorysyndromecoronavirus2coronavirusdisease2019antibodyresponsesinpatientswithatopicdermatitis AT guttmanyasskyemma impactofdupilumabtreatmentonsevereacuterespiratorysyndromecoronavirus2coronavirusdisease2019antibodyresponsesinpatientswithatopicdermatitis |